PHASE II CLINICAL TRIAL OF CAPECITABINE IN THE TREATMENT OF ADVANCED, PERSISTENT OR RECURRENT SQUAMOUS CELL CARCINOMA OF THE CERVIX WITH TRANSLATIONAL RESEARCH: A GYNECOLOGIC ONCOLOGY GROUP STUDY

PURPOSE: To evaluate the anti-tumor activity and adverse events of capecitabine in advanced, persistent or recurrent squamous cell carcinoma of the cervix, and to explore biomarkers with the potential to predict capecitabine response and toxicity. EXPERIMENTAL DESIGN: Eligible, consenting patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garcia, Agustin A., Blessing, John A., Darcy, Kathleen M., Lenz, Heinz Josef, Zhang, Wu, Hannigan, Ed, Moore, David H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1858667/
https://ncbi.nlm.nih.gov/pubmed/17049588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2006.09.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados